FindTrial
Sign In

A study to know the efficacy of granisetron in the prevention of post-spinal shivering in caesarean section.

Granisetron for the prevention of post-spinal shivering in caesarean section: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034744
Enrollment
86
Registered
2021-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Intravenous Granisetron, : 1.Inj. Granisetron 2mg diluted with 3ml of normal saline will be given intravenously before commencing the spinal anaesthesia. Intervention2: Intravenous Gr

Sponsors

Anita Gurung
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women of age group 18-45years 2. ASA I and II

Exclusion criteria

Exclusion criteria: 1. Patients with h/o allergy to study drug 2. Cardiac, respiratory disease, renal and neurological disease. 3. Local site infection 4. Spinal deformity 5. Bleeding disorders

Design outcomes

Primary

MeasureTime frame
appearance and disappearance of shivering after spinal anaesthesia. Grades of shivering.Timepoint: Onset and duration of shivering after spinal anaesthesia—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Longjam Eshori

Regional Institute of Medical Sciences, Imphal

drlongjam@gmail.com9436036407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026